alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.22  


 Anacor Pharmaceuticals, Inc.  


 Change of Control Agreement for Lucy Shapiro, Ph.D.  


        In the event of a Change of Control of Anacor Pharmaceuticals, Inc. (the "Company"), all restricted stock and stock options
granted to you by the Company and held by you shall immediately vest as of the date immediately prior to the effective date of the Change of Control transaction. For purposes of this Agreement, a
"Change of Control" shall mean a sale of all or substantially all of the Company's assets or of equity securities representing more than 50% of the total voting power of the Company, or any merger or
consolidation of the Company with or into another corporation other than a merger or consolidation in which the holders of more than 50% of the shares of capital stock of the Company outstanding
immediately prior to such transaction continue to hold (either by voting securities remaining outstanding or by their being converted into voting securities of the surviving entity) more than 50% of
the total voting power represented by the voting securities of the Company, or such surviving entity, outstanding immediately after such transaction. For purposes of clarification, an equity financing
in which the investors are primarily venture capital or other financial investors will not be a Change of Control, even if equity securities representing greater than 50% of the total voting power of
the Company are sold. 


        You
shall be entitled to receive the acceleration benefit to the extent of the maximum after-tax benefit to you, after taking into account any excise tax that may be imposed
upon the benefit that is characterized as an "excess parachute payment" under applicable law. You are advised to consult with your own tax or financial advisor to understand the possible financial and
tax implications as a result of receiving any such benefits. 

 










			
	AGREED AND ACCEPTED:	 	 
	
 /s/ LUCY SHAPIRO






  Lucy Shapiro, Ph.D.	
 	
 10/25/06






  Date
	
 ANACOR PHARMACEUTICALS, INC.	
 	
 
	
 /s/ DAVID PERRY






  David Perry

Chief Executive Officer	
 	
 10/24/06






  Date



 

 1
#### The People of the State of New York, Respondent, v Darnell Nixon, Appellant.

Appeal by the defendant from a judgment of the Supreme Court, Queens County (Sherman, J.), rendered January 9, 1987, convicting him of attempted robbery in the first degree and robbery in the third degree, upon a jury verdict, and imposing sentence. The appeal brings up for review the denial, after a hearing, of that branch of the defendant’s omnibus motion which was to suppress identification testimony.

Ordered that the judgment is affirmed.

Contrary to the defendant’s contention we find that the police had probable cause to arrest him based upon information supplied by a citizen informant. The evidence adduced at the suppression hearing demonstrated that the informant identified herself to two police officers as the defendant’s cousin and informed them that the defendant had bragged to her about robbing a gas station "twice before”. She then brought the officers to the home she shared with the defendant where, after being granted permission by the defendant’s grandaunt to search the house, they found and took the defendant into custody in connection with two recent robberies of a nearby gas station. Under these circumstances, we will not disturb the hearing court’s determination denying suppression of the subsequent identification of the defendant in a lineup.

We have reviewed the defendant’s remaining contentions concerning the lineup and the court’s charge and find them to be without merit. Kunzeman, J. P., Hooper, Sullivan and Balletta, JJ., concur.
Exhibit 10.31
 INVERNESS MEDICAL INNOVATIONS, INC.
2001 STOCK OPTION AND INCENTIVE PLAN
 NON-QUALIFIED STOCK OPTION AGREEMENT
FOR U.S. EXECUTIVES




---



##### 



Name of Optionee:Number of Option Shares:Option Exercise Price Per Share:Grant Date:Expiration Date:
  Exercisability Schedule
 Number of
    
    Total Number ofExercisability
    
    Option Shares First
    
    Option SharesDate
    
    Becoming Exercisable
    
    Exercisable(25%)
    
    (25%)(25%)
    
    (50%)(25%)
    
    (75%)(25%)
    
    (100%)
 1




---



##### 



Manner of Exercise
     2




---



##### 



Termination of Employment
 Termination Due to Death
 Termination Due to Disability
 Termination for Cause
 Other Termination
 3




---



##### 



provided that
   Incorporation of Plan
 Securities Law Compliance
 Transferability
 4




---



##### 



Tax Withholding
    5




---



##### 



Miscellaneous
    Code Section 409A
 No Advice Regarding Grant
 Electronic Delivery and Acceptance
 Severability
 Imposition of Other Requirements
 6




---



##### 



Governing Law and Venue
   For:
    
    INVERNESS MEDICAL
INNOVATIONS, INC.By:Title: Treasurer
  Optionees SignatureOptionees name and address:
 7
SUBMISSION COVER SHEET

IMPORTANT: Check box if Confidential Treatment is requested

Registered Entity Identifier Code (optional): 22-495

Organization: Chicago Mercantile Exchange Inc. ("CME")

Filing as a: DCM SEF DCO SDR 

Please note - only ONE choice allowed.

Filing Date (mm/dd/yy): 11/21/22 Filing Description: Weekly Notification of Rule 

Amendments - Week of November 14, 2022

SPECIFY FILING TYPE 

Please note only ONE choice allowed per Submission.

Organization Rules and Rule Amendments

Certification § 40.6(a)

Approval § 40.5(a)

Notification § 40.6(d)

Advance Notice of SIDCO Rule Change § 40.10(a)

SIDCO Emergency Rule Change § 40.10(h)

Rule Numbers: N/A

New Product Please note only ONE product per Submission.

Certification § 40.2(a) 

Certification Security Futures § 41.23(a)

Certification Swap Class § 40.2(d)

Approval § 40.3(a)

Approval Security Futures § 41.23(b)

Novel Derivative Product Notification § 40.12(a)

Swap Submission § 39.5

Official Product Name:

Product Terms and Conditions (product related Rules and Rule Amendments)

Certification § 40.6(a) 

Certification Made Available to Trade Determination § 40.6(a)

Certification Security Futures § 41.24(a)

Delisting (No Open Interest) § 40.6(a) 

Approval § 40.5(a)

Approval Made Available to Trade Determination § 40.5(a)

Approval Security Futures § 41.24(c)

Approval Amendments to enumerated agricultural products § 40.4(a), § 40.5(a)

“Non-Material Agricultural Rule Change” § 40.4(b)(5)

Notification § 40.6(d)

 Official Name(s) of Product(s) Affected: 

Rule Numbers: 
300 Vesey Street New York, NY 10282 T 212 299 2200 F 212 301 4645 christopher.bowen@cmegroup.com cmegroup.com

1

Christopher Bowen 

Managing Director and Chief Regulatory Counsel

Legal Department

November 21, 2022

VIA ELECTRONIC PORTAL

Christopher J. Kirkpatrick

Office of the Secretariat

Commodity Futures Trading Commission

Three Lafayette Centre

1155 21st Street, N.W.

Washington, DC 20581

RE: Weekly Notification of Rule Amendments

CME Clearing Submission No. 22-495

Dear Mr. Kirkpatrick:

Pursuant to Commission Regulation 40.6(d), the clearing house division of Chicago Mercantile Exchange Inc. (“CME 

Clearing”) submits this Weekly Notification of the following rule amendments issued during the week of November 14, 

2022: 

• Clearing House Advisory Notice 22-443 (November 15, 2022), Performance Bond Requirements: Equity, 

FX, and Interest Rate Margins - Effective November 16, 2022

• Clearing House Advisory Notice 22-446 (November 17, 2022), Performance Bond Requirements: Energy, 

Equity, FX, and Interest Rate Margins - Effective November 18, 2022

• Clearing House Advisory Notice 22-447 (November 17, 2022), Performance Bond Requirements: Energy -

Effective November 18, 2022

Copies of the above-referenced materials are available at www.cmegroup.com. If you require any additional 

information, please e-mail CMEGSubmissionInquiry@cmegroup.com or contact the undersigned at (212) 299-2200.

Sincerely,

/s/ Christopher Bowen

Managing Director and Chief Regulatory Counsel
# C_2019172EN.01002501.xml

| 20.5.2019 | EN | Official Journal of the European Union | C 172/25 |
| --- | --- | --- | --- |

20.5.2019

EN

Official Journal of the European Union

C 172/25

---

Order of the President of the Ninth Chamber of the Court of 30 January 2019 (request for a preliminary ruling from the Justice de paix du troisième canton de Charleroi — Belgium) — Frank Casteels v Ryanair DAC, formerly Ryanair Ltd

(Case C-368/18) (1)

(2019/C 172/32)

Language of the case: French

The President of the Ninth Chamber has ordered that the case be removed from the register.

---

(1)  OJ C 285, 13.8.2018.

---
Exhibit 32.1



CERTIFICATION PURSUANT TO



18 U.S.C. SECTION 1350,



AS ADDED BY



SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of United Refining Energy Corp. (the Company) on Form 10-Q for the quarter ended November 30,
2008, as filed with the Securities and Exchange Commission (the Report), I, John A. Catsimatidis, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the
Sarbanes-Oxley Act of 2002, that:



| | 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 2. | To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for
the period covered by the Report.
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|                        |  |     |  |                                                 
|----------------------- |  | --- |  | ------------------------------------------------
|                        |  |    
|Dated: January 14, 2009 |  | By: |  | /s/ John A. Catsimatidis                        
|                        |  |     |  | John A. Catsimatidis Principal Executive
Officer
# C_2019172EN.01000401.xml

| 20.5.2019 | EN | Official Journal of the European Union | C 172/4 |
| --- | --- | --- | --- |

20.5.2019

EN

Official Journal of the European Union

C 172/4

---

Order of the Court (First Chamber) of 31 January 2019 (request for a preliminary ruling from the Tribunal Administrativo e Fiscal de Penafiel — Portugal) — Prosa — Produtos e Serviços Agrícolas v Autoridade Tributária e Aduaneira

(Case C-373/18) (1)

(Reference for a preliminary ruling - Article 99 of the Rules of Procedure of the Court of Justice - Indirect taxes on the raising of capital - Directive 69/335/EEC - Articles 4 and 7 - Incorporation of a capital company - Stamp duty in force on 1 July 1984 - Subsequent abolition of that stamp duty, followed by its reintroduction)

(2019/C 172/04)

Language of the case: Portuguese

Referring court

Tribunal Administrativo e Fiscal de Penafiel

Parties to the main proceedings

Applicant: Prosa — Produtos e Serviços Agrícolas

Defendant: Autoridade Tributária e Aduaneira

Operative part of the order

Article 4(1)(a) and Article 7(1) of Council Directive 69/335/EEC of 17 July 1969 concerning indirect taxes on the raising of capital, as amended by Council Directive 85/303/EEC of 10 June 1985, must be interpreted as precluding national legislation by which a Member State has reintroduced capital duty on the incorporation of a capital company falling within the first of those provisions, which were subject to such duty on 1 July 1984, but which were subsequently exempted from it.

---

(1)  OJ C 294, 20.8.2018.

---
#### Kenneth Valentine AWE, Plaintiff-Appellant, v. LAKEWAY PUBLISHERS OF MO. INC.; R.J. Fishman, President of Lakeway Publishers of Mo. Inc. owner of Lincoln County Journal; Kathy Colbert, Publisher of Lincoln County Journal, Defendants-Appellees.

No. 12-2537.

United States Court of Appeals, Fourth Circuit.

Submitted: April 5, 2013.

Decided: June 3, 2013.

Kenneth Valentine Awe, Appellant Pro Se.

Before NIEMEYER, DIAZ, and FLOYD, Circuit Judges.

Dismissed by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM:

Kenneth V. Awe seeks to appeal the district court’s order dismissing his complaint without prejudice pursuant to 28 U.S.C. § 1915(e)(l)(B)(ii) (2006). This court may exercise jurisdiction only over final orders, 28 U.S.C. § 1291 (2006), and certain interlocutory and collateral orders, 28 U.S.C. § 1292 (2006); Fed.R.Civ.P. 54(b); *Cohen v. Beneficial Indus. Loan Corp.,*337 U.S. 541, 545-46, 69 S.Ct. 1221, 93 L.Ed. 1528 (1949). The order Awe seeks to appeal is neither a final order nor an appealable interlocutory or collateral order. *Domino v. Sugar Workers Local Union 392,*10 F.3d 1064, 1067 (4th Cir.1993) (finding dismissals without prejudice generally unappealable). Accordingly, we dismiss the appeal for lack of jurisdiction. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before this court and argument would not aid the decisional process.

*DISMISSED.*
**Exhibit 99.9**

 

 

 

CONSENT OF INDEPENDENT PETROLEUM ENGINEERS AND GEOLOGISTS

 

We hereby consent to the use and reference to our name and reports evaluating a portion of Encana Corporation’s petroleum and natural gas reserves as of December 31, 2011, and the information derived from our reports, as described or incorporated by reference in: (i) Encana Corporation’s Annual Report on Form 40-F for the year ended December 31, 2011, (ii) Encana Corporation’s Registration Statement on Form F-3 (File No. 333-150453), (iii) Encana Corporation’s Registration Statements on Form S-8 (File Nos. 333-124218, 333-85598 and 333-140856); and (iv) Encana Corporation’s Registration Statement on Form F-9 (File No. 333-165626), filed with the United States Securities and Exchange Commission.

 
|                     | **NETHERLAND,   SEWELL & ASSOCIATES, INC.** |
|--------------------------|-----------------------------------------------------------|
|                     |                                                      |
|                     |                                                      |
|                     | By:                                                       | /s/ G.   Lance Binder |
|                     |                                                      | G. Lance   Binder, P.E. |
|                     |                                                      | Executive   Vice President |
|                     |                                                      |   |
| Dallas,   Texas          |                                                      |   |
| February 23,   2012 |                                                      |   |

 

----
IN THE SUPREME COURT OF PENNSYLVANIA 

In the Matter of 

NICHOLE MARIE RICE SMITH 

PETITION FOR REINSTATEMENT 

FROM INACTIVE STATUS 

: 

: 

: 

: 

: 

: 

: 

No. 104 DB 2016 (No. 59 RST 2016) 

Attorney Registration No. 200855 

(Centre County) 

O R D E R 

PER CURIAM 

AND NOW, this 25th day of August, 2016, the Report and Recommendation of 

Disciplinary Board Member dated August 11, 2016, is approved and it is ORDERED 

that Nichole Marie Rice Smith, who has been on Inactive Status, has never been 

suspended or disbarred, and has demonstrated that he has the moral qualifications, 

competency and learning in law required for admission to practice in the 

Commonwealth, shall be and is, hereby reinstated to active status as a member of the 

Bar of this Commonwealth. The expenses incurred by the Board in the investigation 

and processing of this matter shall be paid by the Petitioner.
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 20-6339

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

v.

ALEX LENARD MCCOY,

Defendant - Appellant.

Appeal from the United States District Court for the Western District of North Carolina, at 

Charlotte. Frank D. Whitney, District Judge. (3:15-cr-00273-FDW-DCK-3; 3:19-cv00613-FDW)

Submitted: June 18, 2020 Decided: June 23, 2020

Before FLOYD, THACKER, and RUSHING, Circuit Judges.

Dismissed by unpublished per curiam opinion.

Alex Lenard McCoy, Appellant Pro Se.

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Alex Lenard McCoy seeks to appeal the district court’s order denying relief on his 

28 U.S.C. § 2255 (2018) motion. The order is not appealable unless a circuit justice or 

judge issues a certificate of appealability. See 28 U.S.C. § 2253(c)(1)(B) (2018). A 

certificate of appealability will not issue absent “a substantial showing of the denial of a 

constitutional right.” 28 U.S.C. § 2253(c)(2) (2018). When the district court denies relief 

on the merits, a prisoner satisfies this standard by demonstrating that reasonable jurists 

could find the district court’s assessment of the constitutional claims debatable or wrong. 

See Buck v. Davis, 137 S. Ct. 759, 773-74 (2017). When the district court denies relief on 

procedural grounds, the prisoner must demonstrate both that the dispositive procedural 

ruling is debatable and that the motion states a debatable claim of the denial of a 

constitutional right. Gonzalez v. Thaler, 565 U.S. 134, 140-41 (2012) (citing Slack v. 

McDaniel, 529 U.S. 473, 484 (2000)). 

We have independently reviewed the record and conclude that McCoy has not made 

the requisite showing. Accordingly, we deny McCoy’s motion for a certificate of 

appealability and dismiss the appeal. We dispense with oral argument because the facts 

and legal contentions are adequately presented in the materials before this court and 

argument would not aid the decisional process. 

DISMISSED
EXHIBIT 31.1 Certification of 
Principal Executive Officer CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Martin Schuermann, President and Chief Executive Officer of Vision Industries Corp., a Florida corporation (the "Company"), certify that: 1.     I have reviewed this amended quarterly report on Form 10-Q of the Company; 2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3.     Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report; 4.     The Companys other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and have: a)     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; b)     Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and c)     Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the Companys most recent fiscal quarter (the Companys fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 5.     The Companys other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Companys auditors and the audit committee of the Companys Board of Directors (or persons performing the equivalent functions): a)     All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Companys ability to record, process, summarize and report financial information; and b)     Any fraud, whether or not material, that involves management or other employees who have a significant role in the Companys internal control over financial reporting. Date:  December 8, 2009  /s/MARTIN SCHUERMANNMartin Schuermann
Principal Executive Officer
[Federal Register Volume 66, Number 100 (Wednesday, May 23, 2001)]
[Notices]
[Page 28533]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-12927]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Alcohol Abuse and Alcoholism; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Alcohol Abuse and 
Alcoholism Special Emphasis Panel
    Date: May 23, 2001.
    Time: 10 am to 5 pm.
    Agenda: To review and evaluate contract proposals.
    Place: 6000 Executive Blvd., Suite 400, Rockville, MD 20852.
    Contact Person: Sean O'Rourke, Scientific Review Administrator, 
Extramural Project Review Branch, National Institute on Alcohol 
Abuse and Alcoholism, National Institutes of Health, Suite 409, 6000 
Executive Boulevard, Bethesda, MD 20892-7003, 301-443-2861.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Alcohol Abuse and 
Alcoholism Special Emphasis Panel.
    Date: June 18, 2001.
    Time: 8:30 am to 4 pm.
    Agenda: To review and evaluate contract proposals.
    Place: 6000 Executive Boulevard, Suite 409, Rockville, MD 20852, 
(Telephone Conference Call).
    Contact Person: Ronald Suddendorf, PhD, Scientific Review 
Administrator, Extramural Project Review Branch, National Institute 
on Alcohol Abuse and Alcoholism, National Institutes of Health, 
Suite 409, 6000 Executive Boulevard, Bethesda, MD 20892-7003, 301-
443-2926.

(Catalogue of Federal Domestic Assistance Program Nos. 93.271, 
Alcohol Research Career Development Awards for Scientists and 
Clinicians; 93.272, Alcohol National Research Service Awards for 
Research Training; 93.273, Alcohol Research Programs; 93.891, 
Alcohol Research Center Grants, National Institutes of Health, HHS)

    Dated: May 16, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-12927 Filed 5-22-01; 8:45 am]
BILLING CODE 4140-01-M